相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Multitasking Potential of Alarmins and Atypical Chemokines
Aphrodite Kapurniotu et al.
FRONTIERS IN MEDICINE (2019)
High mobility group box 1 orchestrates tissue regeneration via CXCR4
Mario Tirone et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
Sonya VanPatten et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance
Mingzhu He et al.
MOLECULAR MEDICINE (2018)
Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert
Geoffrey Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Near-native, site-specific and purification-free protein labeling for quantitative protein interaction analysis by MicroScale Thermophoresis
Tanja Bartoschik et al.
SCIENTIFIC REPORTS (2018)
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
Paul J. Collins et al.
FASEB JOURNAL (2017)
High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
Marco E. Bianchi et al.
IMMUNOLOGICAL REVIEWS (2017)
Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking
Valentina Cecchinato et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Multitarget Drug Discovery and Polypharmacology
Maria Laura Bolognesi et al.
CHEMMEDCHEM (2016)
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
G. C. P. van Zundert et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Small molecules, big targets: drug discovery faces the protein-protein interaction challenge
Duncan E. Scott et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
HMGB1 as biomarker and drug target
Emilie Venereau et al.
PHARMACOLOGICAL RESEARCH (2016)
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
Kotaro Shirakawa et al.
ELIFE (2016)
Modulation of Chemokine Responses: Synergy and Cooperativity
Amanda E. I. Proudfoot et al.
FRONTIERS IN IMMUNOLOGY (2016)
Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
Luca Laraia et al.
CHEMISTRY & BIOLOGY (2015)
Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses
Hyong Woo Choi et al.
MOLECULAR MEDICINE (2015)
Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
H. Yang et al.
CELL DEATH & DISEASE (2015)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Sulfopeptide Probes of the CXCR4/CXCL12 Interface Reveal Oligomer-Specific Contacts and Chemokine Allostery
Joshua J. Ziarek et al.
ACS CHEMICAL BIOLOGY (2013)
Homeostatic and Tissue Reparation Defaults in Mice Carrying Selective Genetic Invalidation of CXCL12/Proteoglycan Interactions
Patricia Rueda et al.
CIRCULATION (2012)
Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
Farhat V. N. Din et al.
GASTROENTEROLOGY (2012)
Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response
Mieke Gouwy et al.
IMMUNOLOGY LETTERS (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
被撤回的出版物: Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1) (Publication with Expression of Concern. See vol. 26, 2020) (Retracted article. See vol. 26, 2020)
Huan Yang et al.
MOLECULAR MEDICINE (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Molecular Interaction Studies Using Microscale Thermophoresis
Moran Jerabek-Willemsen et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
Mapping the IκB Kinase β (IKKβ)-binding Interface of the B14 Protein, a Vaccinia Virus Inhibitor of IKKβ-mediated Activation of Nuclear Factor κB
Camilla T. O. Benfield et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
HMGB proteins: Interactions with DNA and chromatin
Michal Stros
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Protein-binding assays in biological liquids using microscale thermophoresis
Christoph J. Wienken et al.
NATURE COMMUNICATIONS (2010)
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice
Rory R. Koenen et al.
NATURE MEDICINE (2009)
Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12
Christopher T. Veldkamp et al.
PROTEIN SCIENCE (2009)
Cooperativity and biological complexity
Adrian Whitty
NATURE CHEMICAL BIOLOGY (2008)
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Christopher T. Veldkamp et al.
SCIENCE SIGNALING (2008)
An NMR-Based antagonist induced dissociation assay for targeting the ligand-protein and protein-protein interactions in competition binding experiments
Marcin Krajewski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
How to design multi-target drugs: target search options in cellular networks
Tamas Korcsmaros et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities
Luca Mollica et al.
CHEMISTRY & BIOLOGY (2007)
Backbone dynamics of SDF-1α determined by NMR:: Interpretation in the presence of monomer-dimer equilibrium
Olga K. Baryshnikova et al.
PROTEIN SCIENCE (2006)
Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1α (SDF-1α/CXCL12)
Christopher T. Veldkamp et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Improvement of duty-cycle heating compensation in NMR spin relaxation experiments
GNB Yip et al.
JOURNAL OF MAGNETIC RESONANCE (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipeline
WF Vranken et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
A rich chemokine environment strongly enhances leukocyte migration and activities
S Paoletti et al.
BLOOD (2005)
The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin
CT Veldkamp et al.
PROTEIN SCIENCE (2005)
Identification of protein-protein interaction sites from docking energy landscapes
J Fernández-Recio et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
C Dominguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability
C Dalvit et al.
JOURNAL OF BIOMOLECULAR NMR (2001)
HMG 1 and 2: architectural DNA-binding proteins
JO Thomas
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor
M Mayer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water
C Dalvit et al.
JOURNAL OF BIOMOLECULAR NMR (2000)
分享论文
